PATIENT‐REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: RESULTS FROM THE PHASE 3 ALCANZA STUDY. (June 2017) - Prince, H.M.; Dummer, R.; Whittaker, S.; Horwitz, S.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.L.; Wolter, P.; Sanches, J.; Ortiz‐Romero, P.; Akilov, O.; et al.